Qtron Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,446
Closed -$239K – 424
2024
Q2
$239K Hold
3,446
– – 0.03% 426
2024
Q1
$276K Buy
+3,446
New +$307K 0.04% 443
2021
Q3
– Sell
-2,446
Closed -$336K – 309
2021
Q2
$336K Buy
+2,446
New +$335K 0.09% 265
2020
Q1
– Sell
-2,519
Closed -$282K – 228
2019
Q4
$282K Sell
2,519
-11
-0.4% -$1.17K 0.16% 175
2019
Q3
$243K Sell
2,530
-1,097
-30% -$103K 0.15% 196
2019
Q2
$310K Hold
3,627
– – 0.19% 174
2019
Q1
$302K Hold
3,627
– – 0.28% 116
2018
Q4
$233K Buy
+3,627
New +$248K 0.18% 150

Other funds holding CNMD

Qtron Investments's CNMD Position: Q3 2024 in Review

Qtron Investments sold out of CONMED (CNMD) in Q3 2024, closing a stake of 3,446 shares — an estimated $239K sold.

Qtron Investments first reported a position in CNMD in Q4 2018 and held it in 8 quarters. The position peaked at $336K in Q2 2021. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Qtron Investments reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
  • Qtron Investments sold 3,446 CONMED shares in Q3 2024, an estimated $239K.
  • Qtron Investments first reported a position in CONMED in Q4 2018 and held it in 8 quarters.
  • Qtron Investments's CONMED position peaked at $336K in Q2 2021.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Qtron Investments's 13F filing for Q3 2024, filed 13 Nov 2024.